Vorinostat Completed Phase 2 Trials for Renal Cell Carcinoma Recurrent / Stage IV Renal Cell Cancer Treatment

IndicationsStatusPurposePhase
CompletedTreatment2
clinicaltrials.gov IdentifierTitleDrugs
NCT00278395Vorinostat in Treating Patients With Kidney Cancer